On July 24, 2019 X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for the treatment of rare diseases, reported that the management team is scheduled to present at the 39th Annual Canaccord Genuity Growth Conference, and to conduct one-on-one meetings at the BTIG Biotechnology Conference 2019 (Press release, X4 Pharmaceuticals, JUL 24, 2019, View Source [SID1234537710]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Details related to the team’s participation are as follows:

Conference:

39th Annual Canaccord Genuity Growth Conference

Location:

Boston, MA

Presentation Date & Time:

August 7th at 3 pm EDT

Conference:

BTIG Biotechnology Conference 2019

Location:

New York, NY

Date:

August 12th